Bristol Myers Squibb (BMY) Income towards Parent Company (2009 - 2026)
Bristol Myers Squibb (BMY) reported Income towards Parent Company of $2.7 billion for Q1 2026, up 8.81% year-over-year from $2.5 billion in Q1 2025, and up 146.69% on a QoQ basis from $1.1 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Income towards Parent Company data on file, last reported at $2.7 billion in Q1 2026.
- Quarterly Income towards Parent Company rose 8.81% year-over-year to $2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (up 197.81% YoY) and the FY2025 annual result came in at $7.1 billion, up 178.99% from the prior year.
- Income towards Parent Company grew to $2.7 billion in Q1 2026 per BMY's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Income towards Parent Company topped out at $2.7 billion in Q1 2026 and bottomed at -$11.9 billion in Q1 2024.
- The 5-year median for Income towards Parent Company is $1.6 billion (2024), against an average of $883.5 million.
- The widest annual swing landed in 2024, when Income towards Parent Company tumbled 625.28%; it then jumped 1328.95% in 2025.
- Tracing BMY's Income towards Parent Company over 5 years: stood at $2.0 billion in 2022, then dropped by 15.7% to $1.7 billion in 2023, then slumped by 95.55% to $76.0 million in 2024, then jumped by 1328.95% to $1.1 billion in 2025, then jumped by 146.69% to $2.7 billion in 2026.
- Per Business Quant, the three latest BMY Income towards Parent Company figures stand at $2.7 billion (Q1 2026), $1.1 billion (Q4 2025), and $2.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 76.00 Mn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.63 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.48 Bn |
| Jun 30, 2021 | 995.00 Mn |
| Mar 31, 2021 | 1.96 Bn |
| Dec 31, 2020 | -10.09 Bn |
| Sep 30, 2020 | 1.81 Bn |
| Jun 30, 2020 | -146.00 Mn |
| Mar 31, 2020 | -832.00 Mn |
| Dec 31, 2019 | -1.16 Bn |
| Sep 30, 2019 | 1.26 Bn |
| Jun 30, 2019 | 1.34 Bn |
| Mar 31, 2019 | 1.62 Bn |
| Dec 31, 2018 | 1.06 Bn |
| Sep 30, 2018 | 1.80 Bn |
| Jun 30, 2018 | 281.00 Mn |
| Mar 31, 2018 | 1.38 Bn |
| Dec 31, 2017 | -2.44 Bn |
| Sep 30, 2017 | 725.00 Mn |
| Jun 30, 2017 | 800.00 Mn |
| Mar 31, 2017 | 1.41 Bn |
| Dec 31, 2016 | 728.00 Mn |
| Sep 30, 2016 | 1.05 Bn |
| Jun 30, 2016 | 1.03 Bn |
| Mar 31, 2016 | 1.04 Bn |
| Dec 31, 2015 | -346.00 Mn |
| Sep 30, 2015 | 536.00 Mn |
| Jun 30, 2015 | -278.00 Mn |
| Mar 31, 2015 | 1.06 Bn |
| Dec 31, 2014 | -104.00 Mn |
| Sep 30, 2014 | 674.00 Mn |
| Jun 30, 2014 | 282.00 Mn |
| Mar 31, 2014 | 878.00 Mn |
| Dec 31, 2013 | 653.00 Mn |
| Sep 30, 2013 | 704.00 Mn |
| Jun 30, 2013 | 528.00 Mn |
| Mar 31, 2013 | 583.00 Mn |
| Dec 31, 2012 | 909.00 Mn |
| Sep 30, 2012 | -713.00 Mn |
| Jun 30, 2012 | 1.09 Bn |
| Mar 31, 2012 | 1.48 Bn |
| Dec 31, 2011 | 1.32 Bn |
| Sep 30, 2011 | 1.36 Bn |
| Jun 30, 2011 | 1.31 Bn |
| Mar 31, 2011 | 1.37 Bn |
| Dec 31, 2010 | -1.32 Bn |
| Sep 30, 2010 | 1.30 Bn |
| Jun 30, 2010 | 1.27 Bn |
| Mar 31, 2010 | 1.10 Bn |
| Dec 31, 2009 | 7.22 Bn |
| Sep 30, 2009 | 91.00 Mn |
| Jun 30, 2009 | 129.00 Mn |
| Mar 31, 2009 | 1.00 Mn |